Another problem. JN has zero clout and isn't affiliated with a brokerage firm which means that few if any are buying based on his recs. He has been positive on AMBS for a long time and it has done nothing. Until Gerald can find a way to uplist without bending over his shareholders with a huge R/S or bring in revs ASAP, the stock is stuck here. No funds, big money, etc is going to touch this while it is on the OTC. Gerald can talk about shareholder value until the cows come home but nothing he does (as we have seen so far) is actually doing a thing for the share price.
The saying, "show me the money" still applies here. And that's the reality.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.